{"id":"NCT00392288","sponsor":"AstraZeneca","briefTitle":"Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.","officialTitle":"A Multicenter, Multi-national, Randomized, Double-blind, Placebo-controlled, Study to Assess the Efficacy and Safety of Ciclesonide Metered-dose Inhaler (MDI) at 80 μg BID or 40 μg BID for 12 Weeks in Patients Aged 4 to <12 Years With Persistent Asthma.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-09","primaryCompletion":"2008-02","completion":"2008-02","firstPosted":"2006-10-25","resultsPosted":"2009-12-30","lastUpdate":"2017-02-01"},"enrollment":528,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Ciclesonide","otherNames":[]},{"type":"DRUG","name":"Ciclesonide","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo MDI","type":"PLACEBO_COMPARATOR"},{"label":"Ciclesonide MDI 40 µg BID","type":"EXPERIMENTAL"},{"label":"Ciclesonide MDI 80 µg BID","type":"EXPERIMENTAL"}],"summary":"Primary objective: To demonstrate the efficacy of ciclesonide, compared to placebo, at 80 μg twice daily (BID) or 40 μg BID for 12 weeks in patients with persistent asthma.\n\nSecondary objective: To assess the safety and tolerability of ciclesonide.","primaryOutcome":{"measure":"Change From Baseline in Forced Expiratory Volume in One Second (FEV1) at Week 12.","timeFrame":"Baseline and Week 12","effectByArm":[{"arm":"Placebo Metered Dose Inhaler (MDI)","deltaMin":5.2,"sd":1.06},{"arm":"Ciclesonide MDI 40 µg BID","deltaMin":5.3,"sd":1.06},{"arm":"Ciclesonide MDI 80 µg BID","deltaMin":7.7,"sd":1.06}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"0.2696"},{"comp":"OG000 vs OG002","p":"0.0703"},{"comp":"OG000 vs OG001","p":"0.9146"}]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":6,"countries":["United States","Hungary","Mexico","Poland","Russia","South Africa"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":172},"commonTop":["Asthma","Pharyngitis","Headache","Upper respiratory tract infection","Nasopharyngitis"]}}